NXE 0027477
Alternative Names: GSK-4381406; HTL-0027477; NXE'477; NXE-0027477Latest Information Update: 02 Apr 2024
At a glance
- Originator Sosei Heptares
- Developer Nxera Pharma
- Class Anti-inflammatories; Small molecules
- Mechanism of Action GPR35 protein agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammatory bowel diseases